Skip to main content
ZEVRA THERAPEUTICS, INC. logo

ZEVRA THERAPEUTICS, INC. — Investor Relations & Filings

Ticker · ZVRA ISIN · US4884452065 LEI · 254900CU6T74V18Y1W18 US Manufacturing
Open in API
Filings indexed 830 across all filing types
Latest filing 2017-11-29 Director's Dealing
Country US United States of America
Listing US ZVRA

About ZEVRA THERAPEUTICS, INC.

https://zevra.com/

Zevra Therapeutics, Inc. is a commercial-stage biopharmaceutical company dedicated to developing and commercializing therapies for patients with rare diseases. The company focuses on addressing significant unmet medical needs by combining a data-driven scientific approach with a patient-first perspective. Its portfolio includes commercial products such as MIPLYFFA®, an FDA-approved treatment for Niemann-Pick disease type C (NPC), and OLPRUVA®. Zevra Therapeutics also maintains a late-stage clinical pipeline, specializing in advancing promising medicines that face complex clinical and regulatory challenges for conditions with limited or no available treatments.

Recent filings

Filing Released Lang Actions
FORM 4
Director's Dealing
2017-11-29 English
FORM 10-Q
Interim / Quarterly Report Q3 2017
2017-11-09 English
FORM 8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K current report filed with the SEC, dated November 9, 2017. It announces the issuance of a press release and a presentation regarding the company's third quarter 2017 financial results. The document itself does not contain the financial results but references exhibits (press release and presentation) that provide the details. The text explicitly states that the press release and presentation are furnished as exhibits and are not "filed" for purposes of the Exchange Act, indicating this document is an announcement of the earnings release and related materials rather than the earnings release itself. The document length is 3710 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, this filing is best classified as an Earnings Release (ER) announcement within a Form 8-K filing, but since the actual earnings release is attached as an exhibit and the document is a current report announcing results, the most appropriate classification is Earnings Release (ER).
2017-11-09 English
8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K Current Report filed with the SEC, which is used for reporting unscheduled material events or corporate changes. The content discusses NASDAQ listing compliance notifications regarding the company's market value and listing status. It does not contain financial statements or detailed financial performance data, nor is it an announcement of a report publication. It is not a management or earnings report, nor a proxy or voting result. The document is a regulatory announcement about listing compliance status, fitting best under Regulatory Filings (RNS). The document length is short (3096 characters), and it is not a report publication announcement but a substantive regulatory filing. Therefore, the appropriate classification is Regulatory Filings (RNS).
2017-10-02 English
FORM 8-K
Investor Presentation Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events. The text indicates that the company made available an investor presentation on its website and filed a copy of this presentation as Exhibit 99.1. The document itself is short (3372 characters) and primarily serves to announce the availability of the investor presentation rather than containing detailed financial data or the presentation content itself. According to the 'Menu vs Meal' rule, such a document is an announcement of a report (the investor presentation) rather than the report itself. Therefore, the appropriate classification is 'Investor Presentation' (IP).
2017-09-26 English
FORM 4
Director's Dealing
2017-09-25 English

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.